Celularity retires all $41.6M senior secured debt via IP sale and license-back deal

Celularity Inc

Retired all $32M principal plus $9.6M accrued interest on senior secured loans for total $41.6M.
Sold IP assets to Celeniv for $33,812,230; licensed back exclusively with five-year repurchase option.
Created four operating subsidiaries for advanced biomaterials, longevity cell therapy, biobanking, and CDMO.
Proceeds used to retire $27M RWI loan and $6,812,230 promissory note; prior note proceeds retired C.V. Starr loan.
Retained exclusive use of IP; balance sheet improved with removal of general security interest.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.